
Happiness Capital
Description
Happiness Capital is a Hong Kong-based venture capital firm established in 2018, serving as the venture arm of LKK Health Products Group, a member of the venerable Lee Kum Kee Group. With a distinctive mission, the firm is dedicated to investing in startups globally that aim to enhance human happiness and well-being. Their investment philosophy centers on supporting innovative companies that contribute positively to society across various sectors, including health and wellness, sustainable living, education, and the future of work. This strategic alignment with their parent company's values provides them with a robust foundation and a long-term perspective on investment.
The firm adopts a stage-agnostic approach, deploying capital across all investment stages, from seed rounds to growth equity. This flexibility allows Happiness Capital to support promising ventures from their nascent stages through significant scaling. Their global reach is evident in a diverse portfolio that spans continents, reflecting their commitment to finding impactful innovations wherever they emerge. They seek out companies that not only demonstrate strong business fundamentals but also possess a clear vision for creating a happier and healthier future for humanity.
Happiness Capital has built an impressive portfolio of over 60 companies, including well-known names such as Calm, Impossible Foods, MasterClass, and Oatly. Their participation in significant funding rounds, such as the $175 million Series C for The Every Company or the $100 million Series C for Future Family, underscores their capacity to deploy substantial capital into high-growth ventures. While specific check sizes are not publicly disclosed, their involvement in such large rounds, coupled with their investment across all stages, indicates a readiness to write checks ranging from early-stage commitments to multi-million dollar investments in later-stage growth rounds.
Leveraging the extensive resources and global network of the Lee Kum Kee Group, Happiness Capital provides more than just capital. They offer strategic guidance, operational support, and access to a vast ecosystem, helping their portfolio companies achieve their full potential. Their unique focus on "happiness" as an investment thesis positions them as a distinctive player in the venture capital landscape, committed to fostering innovation that delivers both financial returns and positive societal impact.
Investor Profile
Happiness Capital has backed more than 29 startups, with 3 new investments in the last 12 months alone. The firm has led 10 rounds, about 34% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Seed, Series B rounds (top funding stages).
- Majority of deals are located in United States, Germany, United Kingdom.
- Strong thematic focus on Biotechnology, Food and Beverage, Health Care.
- Typical check size: $1M – $20M.
Stage Focus
- Series A (34%)
- Seed (28%)
- Series B (17%)
- Convertible Note (7%)
- Series C (7%)
- Series D (3%)
- Series Unknown (3%)
Country Focus
- United States (34%)
- Germany (31%)
- United Kingdom (17%)
- Israel (7%)
- France (3%)
- Finland (3%)
- Switzerland (3%)
Industry Focus
- Biotechnology
- Food And Beverage
- Health Care
- Health Diagnostics
- Agtech
- Artificial Intelligence (Ai)
- Robotics
- Animal Feed
- Advanced Materials
- Fertility
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.